IP Library Granted Patent US 10,125,349
Granted Patent B2
US 10,125,349 · App. 14/780,873 · Granted Nov 13, 2018

Method for cell culture

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,125,349
App. No.
14/780,873
Granted
Nov 13, 2018
Kind
B2
Abstract

A method for stem or progenitor cell culture. More precisely, the invention relates to a method for cell culture using one or more IαI (inter-alpha trypsin inhibitor or Inter-alpha inhibitor) protein(s) or part(s) thereof as a component in a cell culture media or a coating on a cell culture surface material. Furthermore the invention relates to a cell culture media and a cell culture coating/matrix provided with one or more IαI proteins(s) or part(s) thereof.

Claims (24)

1. A cell free medium for at least one of seeding and culturing stem or progenitor cells on an uncoated surface, the medium comprising a partially or a completely chemically defined cell culture medium which comprises or is supplemented at a concentration of 2 μg/mL-100 μg/mL of one or more inter alpha trypsin inhibitor (IαI) proteins to promote adhesion of said cells to said uncoated surface during the first passage as well as self-renewal of said cells,

wherein the one or more IαI proteins are selected from the group consisting of an IαI protein comprising heavy chain 1 (HC1), heavy chain 2 (HC2), and bikunin (B) (IαI-HC1, HC2, B), an isolated heavy chain 2 (isolated HC2), and an IαI protein comprising heavy chain 2 (IαI-HC2), and

wherein the medium is whole serum free, serum component free and feeder cell free.

2. The medium of claim 1 , wherein the completely chemically defined medium is E8.

3. The medium of claim 1 , wherein the concentration of the one or more IαI proteins of IαI protein family is 10 μg/mL-50 μg/mL.

4. The medium of claim 1 , wherein the one or more IαI proteins are un-complexed proteins isolated from serum or a serum fraction, produced as a recombinant protein, synthesized chemically, or a combination thereof.

5. The medium of claim 1 , wherein the one or more IαI proteins comprise isolated HC2.

6. The medium of claim 1 , further comprising Rho-associated kinase inhibitor (ROCKi).

7. The medium of claim 1 , wherein the partially chemically defined medium is 2i medium.

8. A cell free medium for at least one of seeding and culturing stem or progenitor cells on an uncoated surface, the medium comprising a partially or a completely chemically defined cell culture medium which comprises or is supplemented at a concentration of 2 μg/mL-100 μg/mL of an IαI-HC1, HC2, B to promote adhesion of said cells to said uncoated surface during the first passage as well as self-renewal of said cells,

wherein the medium is whole serum free, serum component free and feeder cell free.

9. The medium of claim 8 , wherein the completely chemically defined medium is E8.

10. The medium of claim 8 , wherein the concentration of the IαI protein is 10 μg/mL-50 μg/mL.

11. The medium of claim 8 , wherein the IαI protein is an un-complexed protein isolated from serum or a serum fraction, produced as a recombinant protein, synthesized chemically, or a combination thereof.

12. The medium of claim 8 , further comprising Rho-associated kinase inhibitor (ROCKi).

13. The medium of claim 8 , wherein the partially chemically defined medium is 2i medium.

14. A cell free medium for at least one of seeding and culturing stem or progenitor cells on an uncoated surface, the medium comprising a partially or completely chemically defined cell culture medium and comprises or is being supplemented at a concentration of 2 μg/mL-100 μg/mL with an inter alpha trypsin inhibitor (IαI) protein that comprises heavy chain 2 (IαI-HC2) to promote adhesion of said cells to said uncoated surface during the first passage as well as self-renewal of said cells,

wherein the medium is whole serum free, serum component free and feeder cell free.

15. The medium of claim 14 , wherein the completely chemically defined medium is E8.

16. The medium of claim 14 , wherein the concentration of the IαI protein is 10 μg/mL-50 μg/mL.

17. The medium of claim 14 , wherein the IαI-HC2 is un-complexed proteins isolated from serum or a serum fraction, produced as a recombinant protein, synthesized chemically, or a combination thereof.

18. The medium of claim 14 , wherein said medium is used on an uncoated surface.

19. The medium of claim 14 , further comprising Rho-associated kinase inhibitor (ROCKi).

20. The medium of claim 14 , wherein the partially chemically defined medium is 2i medium.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2015
From: PIJUAN GALITO, SARA; TAMM, CHRISTOFFER; ANNEREN, CECILIA
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 036672/0179 →